Anti-inflammatory and Protective Properties of Daphnetin in endotoxin-induced lung injury

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 51, 2014, Pages 12315-12325

  Yu, Wen Wen ^a,b   Lu, Zhe ^a   Zhang, Hang ^a   Kang, Yan Hua ^a   Mao, Yun ^a   Wang, Huan Huan ^a   Ge, Wei Hong ^b   Shi, Li Yun ^a  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Lung injury; Ubiquitination

Indexed keywords

BIOLOGICAL ORGANS; ENZYME ACTIVITY; MACROPHAGES; PATHOLOGY;

ALVEOLAR EPITHELIAL CELLS; INFLAMMATION; INFLAMMATORY MEDIATORS; INFLAMMATORY RESPONSE; INFLAMMATORY SIGNALING; LUNG INJURY; PROTECTIVE PROPERTIES; UBIQUITINATION;

CELL SIGNALING;

ANTIINFLAMMATORY AGENT; DAPHNETIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; UMBELLIFERONE DERIVATIVE;

ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; LUNG INJURY; MACROPHAGE; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ENDOTOXINS; HUMANS; LUNG INJURY; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTECTIVE AGENTS; TUMOR NECROSIS FACTOR-ALPHA; UMBELLIFERONES;

EID: 84919715765     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf503667v     Document Type: Article

References (49)

1. Wheeler, A. P.; Bernard, G. R. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369 (9572), 1553-1564.
2. Rubenfeld, G. D.; Caldwell, E.; Peabody, E.; Weaver, J.; Martin, D. P.; Neff, M.; Stern, E. J.; Hudson, L. D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353 (16), 1685-1693.
3. Karin, M.; Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol. 2002, 3 (3), 221-227.
4. Hoffmann, A.; Levchenko, A.; Scott, M. L.; Baltimore, D. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science 2002, 298 (5596), 1241-1245.
5. Medzhitov, R.; Horng, T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9 (10), 692-703.
6. Hochstrasser, M. Biochemistry. All in the ubiquitin family. Science 2000, 289 (5479), 563-564.
7. Hochstrasser, M. Lingering mysteries of ubiquitin-chain assembly. Cell 2006, 124 (1), 27-34.
8. Reiley, W. W.; Zhang, M.; Jin, W.; Losiewicz, M.; Donohue, K. B.; Norbury, C. C.; Sun, S. C. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat. Immunol. 2006, 7 (4), 411-417.
9. Sun, S. C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 2008, 8 (7), 501-511.
10. Mabilleau, G.; Chappard, D.; Sabokbar, A. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J. Biol. Chem. 2011, 286 (5), 3242-3249.
11. Shembade, N.; Ma, A.; Harhaj, E. W. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327 (5969), 1135-1139.
12. Vereecke, L.; Beyaert, R.; van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009, 30 (8), 383-391.
13. Wang, J.; Ouyang, Y.; Guner, Y.; Ford, H. R.; Grishin, A. V. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J. Immunol. 2009, 183 (2), 1384-1392.
14. Gon, Y.; Asai, Y.; Hashimoto, S.; Mizumura, K.; Jibiki, I.; Machino, T.; Ra, C.; Horie, T. A20 inhibits toll-like receptor 2-and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2004, 31 (3), 330-336.
15. Onose, A.; Hashimoto, S.; Hayashi, S.; Maruoka, S.; Kumasawa, F.; Mizumura, K.; Jibiki, I.; Matsumoto, K.; Gon, Y.; Kobayashi, T.; Takahashi, N.; Shibata, Y.; Abiko, Y.; Shibata, T.; Shimizu, K.; Horie, T. An inhibitory effect of A20 on NF-κB activation in airway epithelium upon influenza virus infection. Eur. J. Pharmacol. 2006, 541 (3), 198-204.
16. Kelly, C.; Williams, M. T.; Elborn, J. S.; Ennis, M.; Schock, B. C. Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis. J. Cyst. Fibros. 2013, 12 (4), 411-415.
17. Kelly, C.; Shields, M. D.; Elborn, J. S.; Schock, B. C. A20 regulation of nuclear factor-κB: perspectives for inflammatory lung disease. Am. J. Respir. Cell Mol. Biol. 2011, 44 (6), 743-748.
18. Venugopala, K. N.; Rashmi, V.; Odhav, B. Review on natural coumarin lead compounds for their pharmacological activity. Biomed. Res. Int. 2013, 2013, No. 963248.
19. Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas, K. E.; Nicolaides, D. N. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr. Pharm. Des. 2004, 10 (30), 3813-3833.
20. Tu, L.; Li, S.; Fu, Y.; Yao, R.; Zhang, Z.; Yang, S.; Zeng, X.; Kuang, N. The therapeutic effects of daphnetin in collagen-induced arthritis involve its regulation of Th17 cells. Int. Immunopharmacol. 2012, 13 (4), 417-423.
21. Yao, R.; Fu, Y.; Li, S.; Tu, L.; Zeng, X.; Kuang, N. Regulatory effect of daphnetin, a coumarin extracted from Daphne odora, on the balance of Treg and Th17 in collagen-induced arthritis. Eur. J. Pharmacol. 2011, 670 (1), 286-294.
22. Bosmann, M.; Grailer, J. J.; Zhu, K.; Matthay, M. A.; Sarma, J. V.; Zetoune, F. S.; Ward, P. A. Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury. FASEB J. 2012, 26 (5), 2137-2144.
23. Dela, C. C.; Liu, W.; He, C. H.; Jacoby, A.; Gornitzky, A.; Ma, B.; Flavell, R.; Lee, C. G.; Elias, J. A. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe 2012, 12 (1), 34-46.
24. Liu, G.; Friggeri, A.; Yang, Y.; Park, Y. J.; Tsuruta, Y.; Abraham, E. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (37), 15819-15824.
25. Hsu, L. C.; Liang, Y. H.; Hsu, Y. W.; Kuo, Y. H.; Pan, T. M. Anti-inflammatory properties of yellow and orange pigments from Monascus purpureus NTU 568. J. Agric. Food Chem. 2013, 61 (11), 2796-2802.
26. Kang, Y.; Wang, F.; Lu, Z.; Ying, H.; Zhang, H.; Ding, W.; Wang, C.; Shi, L. MAPK kinase 3 potentiates Chlamydia HSP60- induced inflammatory response through distinct activation of NF-κB. J. Immunol. 2013, 191 (1), 386-394.
27. Yang, M.; Wang, C.; Zhu, X.; Tang, S.; Shi, L.; Cao, X.; Chen, T. E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKCζ. J. Exp. Med. 2011, 208 (10), 2099-2112.
28. Do-Umehara, H. C.; Chen, C.; Urich, D.; Zhou, L.; Qiu, J.; Jang, S.; Zander, A.; Baker, M. A.; Eilers, M.; Sporn, P. H.; Ridge, K. M.; Sznajder, J. I.; Budinger, G. R.; Mutlu, G. M.; Lin, A.; Liu, J. Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-δ. Nat. Immunol. 2013, 14 (5), 461-469.
29. Islam, M. N.; Das, S. R.; Emin, M. T.; Wei, M.; Sun, L.; Westphalen, K.; Rowlands, D. J.; Quadri, S. K.; Bhattacharya, S.; Bhattacharya, J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 2012, 18 (5), 759-765.
30. Sato, S.; Sanjo, H.; Takeda, K.; Ninomiya-Tsuji, J.; Yamamoto, M.; Kawai, T.; Matsumoto, K.; Takeuchi, O.; Akira, S. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005, 6 (11), 1087-1095.
31. Park, W. Y.; Goodman, R. B.; Steinberg, K. P.; Ruzinski, J. T.; Radella, F. N.; Park, D. R.; Pugin, J.; Skerrett, S. J.; Hudson, L. D.; Martin, T. R. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001, 164 (10 Part 1), 1896-1903.
32. Lim, J. H.; Stirling, B.; Derry, J.; Koga, T.; Jono, H.; Woo, C. H.; Xu, H.; Bourne, P.; Ha, U. H.; Ishinaga, H.; Xu, H.; Andalibi, A.; Feng, X. H.; Zhu, H.; Huang, Y.; Zhang, W.; Weng, X.; Yan, C.; Yin, Z.; Briles, D. E.; Davis, R. J.; Flavell, R. A.; Li, J. D. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 2007, 27 (2), 349-360.
33. Deng, J. C.; Cheng, G.; Newstead, M. W.; Zeng, X.; Kobayashi, K.; Flavell, R. A.; Standiford, T. J. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 2006, 116 (9), 2532-2542.
34. Wang, C.; Deng, L.; Hong, M.; Akkaraju, G. R.; Inoue, J.; Chen, Z. J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001, 412 (6844), 346-351.
35. Yu, Y.; Ge, N.; Xie, M.; Sun, W.; Burlingame, S.; Pass, A. K.; Nuchtern, J. G.; Zhang, D.; Fu, S.; Schneider, M. D.; Fan, J.; Yang, J. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NFκB and AP-1 activation as well as IL-6 gene expression. J. Biol. Chem. 2008, 283 (36), 24497-24505.
36. Sakurai, H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 2012, 33 (10), 522-530.
37. Ahmed, N.; Zeng, M.; Sinha, I.; Polin, L.; Wei, W. Z.; Rathinam, C.; Flavell, R.; Massoumi, R.; Venuprasad, K. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat. Immunol. 2011, 12 (12), 1176-1183.
38. Bhattacharyya, S.; Ratajczak, C. K.; Vogt, S. K.; Kelley, C.; Colonna, M.; Schreiber, R. D.; Muglia, L. J. TAK1 targeting by glucocorticoids determines JNK and IκB regulation in Toll-like receptor-stimulated macrophages. Blood 2010, 115 (10), 1921-1931.
39. Chen, B. B.; Coon, T. A.; Glasser, J. R.; McVerry, B. J.; Zhao, J.; Zhao, Y.; Zou, C.; Ellis, B.; Sciurba, F. C.; Zhang, Y.; Mallampalli, R. K. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat. Immunol. 2013, 14 (5), 470-479.
40. Deng, L.; Wang, C.; Spencer, E.; Yang, L.; Braun, A.; You, J.; Slaughter, C.; Pickart, C.; Chen, Z. J. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103 (2), 351-361.
41. Song, Z.; Yao, C.; Yin, J.; Tong, C.; Zhu, D.; Sun, Z.; Jiang, J.; Shao, M.; Zhang, Y.; Deng, Z.; Tao, Z.; Sun, S.; Bai, C. Genetic variation in the TNF receptor-associated factor 6 gene is associated with susceptibility to sepsis-induced acute lung injury. J. Transl. Med. 2012, 10, 166.
42. Boone, D. L.; Turer, E. E.; Lee, E. G.; Ahmad, R. C.; Wheeler, M. T.; Tsui, C.; Hurley, P.; Chien, M.; Chai, S.; Hitotsumatsu, O.; McNally, E.; Pickart, C.; Ma, A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 2004, 5 (10), 1052-1060.
43. Heger, K.; Fierens, K.; Vahl, J. C.; Aszodi, A.; Peschke, K.; Schenten, D.; Hammad, H.; Beyaert, R.; Saur, D.; van Loo, G.; Roers, A.; Lambrecht, B. N.; Kool, M.; Schmidt-Supprian, M. A20-deficient mast cells exacerbate inflammatory responses in vivo. PLoS Biol. 2014, 12 (1), No. e1001762.
44. Zhao, J.; Wei, J.; Mialki, R. K.; Mallampalli, D. F.; Chen, B. B.; Coon, T.; Zou, C.; Mallampalli, R. K.; Zhao, Y. F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat. Immunol. 2012, 13 (7), 651-658.
45. Tiesset, H.; Pierre, M.; Desseyn, J. L.; Guery, B.; Beermann, C.; Galabert, C.; Gottrand, F.; Husson, M. O. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J. Nutr. 2009, 139 (1), 82-89.
46. Maelfait, J.; Roose, K.; Bogaert, P.; Sze, M.; Saelens, X.; Pasparakis, M.; Carpentier, I.; van Loo, G.; Beyaert, R. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection. PLoS Pathog. 2012, 8 (3), No. e1002570.
47. Kang, N. I.; Yoon, H. Y.; Lee, Y. R.; Won, M.; Chung, M. J.; Park, J. W.; Hur, G. M.; Lee, H. K.; Park, B. H. A20 attenuates allergic airway inflammation in mice. J. Immunol. 2009, 183 (2), 1488-1495.
48. Lee, M. S.; Kwon, M. S.; Choi, J. W.; Shin, T.; No, H. K.; Choi, J. S.; Byun, D. S.; Kim, J. I.; Kim, H. R. Anti-inflammatory activities of an ethanol extract of Ecklonia stolonifera in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells. J. Agric. Food Chem. 2012, 60 (36), 9120-9129.
49. Kontogiorgis, C.; Detsi, A.; Hadjipavlou-Litina, D. Coumarin-based drugs: a patent review (2008-present). Expert. Opin. Ther. Pat. 2012, 22 (4), 437-454.